Dr. Reddy’s Laboratories Ltd Receives EIR For Duvvada Formulations Plant

Dr. Reddy’s Laboratories Ltd. has announced regarding the audit of its Formulations Manufacturing Plant (“Vizag SEZ Plant I – PTO 7”) at Duvvada, Visakhapatnam. The company has now received the Establishment Inspection Report (EIR) from US FDA, for the above-referred facility, indicating closure of the audit. As intimated earlier the facility has been classified as VAI (Voluntary Action Indicated).

Shares of DR.REDDY’s LABORATORIES LTD. was last trading in BSE at Rs.3256.5 as compared to the previous close of Rs. 3276.85. The total number of shares traded during the day was 16014 in over 1729 trades.

The stock hit an intraday high of Rs. 3363 and intraday low of 3245. The net turnover during the day was Rs. 53049893.-Equity Bulls

Share this:

Related Post

Stay Updated on Medical Equipment and Devices industry.
Receive our Daily Newsletter.